IRVINE — Allergan Inc. and Peptech Ltd. in England have terminated their agreement to develop a psoriasis treatment.
Irvine-based Allergan, an eye-care products company, said Peptech has determined that further work is required to assess the optimal treatment regimen for the product, GMDP.
